In addition, in the subgroup analysis we found that positive Cbl-b expression indicated favorable prognosis mainly in patients with histological grade 2–3, lymph node metastasis, and stage II–III. This evidence concerns the gene CBLB and metastatic malignant neoplasm in the lymph nodes.